Gloria Ying (06821) participated in the investment fund to complete business registration

Zhitong Finance App News, Gloria Ying (06821) issued an announcement. The company held the 50th meeting of the 4th board of directors on April 29, 2024 to review and pass the “Proposal on Wholly-owned Subsidiaries to Participate in Investment Funds and Related Transactions”, agreeing to invest 30 million yuan as a wholly-owned subsidiary Gloria Life Science Technology (Tianjin) as a limited partner with Tianjin Xinyin Hengze Management Consulting Partnership (Limited Partnership), Haizunchuang (Tianjin) Enterprise Management Consulting Partnership (Limited Partnership), Tianjin Haihe Industrial Fund Partnership Limited (Limited Partnership) Partnership), Tianjin Eco-City State-owned

Zhitong Finance06:31 ET

Yao Ming Kangde (02359) spent about 2.046 million yuan to buy back about 438,400 A shares on May 6

According to the Zhitong Finance App, Yao Ming Kangde (02359) announced that on May 6, 2024, it spent about 2.046 million yuan to buy back about 438,400 A-shares.

Zhitong Finance06:16 ET

Fosun Pharmaceutical (02196.HK) has yet to repurchase shares

Gelonghui, May 6, 丨 Fosun Pharmaceutical (02196.HK) issued an announcement. From March 26, 2024 (that is, the date the board of directors reviewed and approved the repurchase plan) to April 30, 2024, the company has not yet repurchased shares under the repurchase plan.

Gelonghui Finance05:52 ET

Gloria Ying (002821.SZ): 2.02% of shares have been repurchased cumulatively

Glonghui, May 6, 丨 Gloria Ying (002821.SZ) announced that as of April 30, 2024, the total number of shares repurchased by the company through centralized bidding through a special securities account was 6,898,369 shares, accounting for 2.0175% of the company's total A share capital. The highest transaction price was 10.2.00 yuan/share, and the minimum transaction price was 75.53 yuan/share. The total amount paid was 578 million yuan (excluding transaction fees).

Gelonghui Finance05:12 ET

Wantai Biotech (603392.SH): Has repurchased a total of 539,500 shares

Gelonghui, May 6, 丨 Wantai Biotech (603392.SH) announced that as of April 30, 2024, the company had repurchased 539,500 shares through centralized bidding transactions, accounting for 0.0425% of the company's total share capital. The highest price of the repurchase transaction was 70.19 yuan/share, the lowest price was 45.55 yuan/share, and the total amount of capital paid was RMB 28,651,117.96 (not including transaction fees such as transaction fees).

Gelonghui Finance04:41 ET

Earnings Troubles May Signal Larger Issues for Bloomage BioTechnology (SHSE:688363) Shareholders

Bloomage BioTechnology Corporation Limited's (SHSE:688363) recent weak earnings report didn't cause a big stock movement. We think that investors are worried about some weaknesses underlying the earn

Simply Wall St03:03 ET